British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy
Title: UK Drug Pricing Authority Endorses AbbVie’s Ovarian Cancer Treatment
NICE, the National Institute for Health and Care Excellence, has advised that AbbVie’s new therapy for ovarian cancer should be made available within the NHS. The watchdog’s recommendation clears the way for the drug to be prescribed to eligible patients, marking a significant step in expanding treatment options for those affected by the disease.
Source: Yahoo News Generated at: 2026-06-03 23:59:24 UTC
